Report overview
Local anesthetics are commonly used in the department of stomatology, ophthalmology, gynecology and some minor surgeries to temporarily relieve pain. The fundamental difference between local anaesthesia and general anaesthesia lies in that after the combination of local anaesthesia with some specific parts of the sodium ion channel on the nerve membrane, the sodium ion in the sodium ion channel decreases so as to change the nerve membrane potential, causing the conduction of nerve impulse to be blocked, and finally realize the anesthetic effect. General anesthesia, on the other hand, works by affecting the physical properties of the membrane, such as the fluid and permeability of the membrane.
This report contains market size and forecasts of Local Anesthesia Drugs in global, including the following market information:
Global Local Anesthesia Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Local Anesthesia Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Local Anesthesia Drugs companies in 2021 (%)
The global Local Anesthesia Drugs market was valued at 4374.6 million in 2021 and is projected to reach US$ 5027.7 million by 2028, at a CAGR of 2.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Articaine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Local Anesthesia Drugs include Mylan, Novartis, Fresenius Kabi, Aspen Pharmacare, Sagent Pharmaceutical, Pacira Pharmaceutical, Teva Pharmaceuticals and Pierrel, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Local Anesthesia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Local Anesthesia Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Local Anesthesia Drugs Market Segment Percentages, by Type, 2021 (%)
Articaine
Bupivacaine
Lidocaine
Mepivacaine
Prilocaine
Global Local Anesthesia Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Local Anesthesia Drugs Market Segment Percentages, by Application, 2021 (%)
Stomatology
Ophthalmology
Gynecology
Other
Global Local Anesthesia Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Local Anesthesia Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Local Anesthesia Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Local Anesthesia Drugs revenues share in global market, 2021 (%)
Key companies Local Anesthesia Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Local Anesthesia Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan
Novartis
Fresenius Kabi
Aspen Pharmacare
Sagent Pharmaceutical
Pacira Pharmaceutical
Teva Pharmaceuticals
Pierrel
